Study identifies inflammatory immune pathway driving immunotherapy resistance in bladder cancer

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy. Their findings, published in…

Continue Reading

News Source: medicalxpress.com